Trypanosoma cruzi infection results in the reduced expression of caveolin-3 in the heart

Cell Cycle

Volumn 9, Issue 8, 2010, Pages 1639-1646

  Adesse, Daniel ^a,b   Lisanti, Michael P ^d,e   Spray, David C ^b   Machado, Fabiana S ^c   Meirelles, Maria De Nazareth ^a   Tanowitz, Herbert B ^b   Garzoni, Luciana Ribeiro ^a  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^c FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^d THOMAS JEFFERSON UNIVERSITY   (United States)

^e UNIVERSITY OF GENOA   (Italy)

Author keywords

Cardiac myocytes; Caveolae; Caveolin 3; ERK; Trypanosoma cruzi

Indexed keywords

CAVEOLIN 3; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL ULTRASTRUCTURE; CHAGAS DISEASE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CYTOCHEMISTRY; DISEASE COURSE; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; HEART MUSCLE CELL; IMMUNOHISTOCHEMISTRY; MALE; MOUSE; NONHUMAN; PHENOTYPE; PROTEIN EXPRESSION;

MUS; TRYPANOSOMA CRUZI;

EID: 77953559355     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/cc.9.8.11509     Document Type: Article

References (39)

1. Chagas C. Nova espécie morbida do homem, produzida por um Trypanosoma (Trypanosoma cruzi): Nota prévia, Brasil Médico 1909; 23:161.
2. Tanowitz HB, Machado FS, Jelicks LA, Shirani J, de Carvalho AC, Spray DC, et al. Perspectives on Trypanosoma cruzi-induced heart disease (Chagas disease). Prog Cardiovasc Dis 2009; 51:524-39.
3. Huang H, Chan J, Wittner M, Jelicks LA, Morris SA, Factor SM, et al. Expression of cardiac cytokines and inducible form of nitric oxide synthase (NOS2) in Trypanosoma cruzi-infected mice. J Mol Cell Cardiol 1999; 31:75-88.
4. Machado FS, Souto JT, Rossi MA, Esper L, Tanowitz HB, Aliberti J, et al. Nitric oxide synthase-2 modulates chemokine production by Trypanosoma cruzi-infected cardiac myocytes. Microbes Infect 2008; 10:1558-66.
5. Punukollu G, Gowda RM, Khan IA, Navarro VS, Vasavada BC. Clinical aspects of the Chagas' heart disease. Int J Cardiol 2006.
6. Meirelles MN, de Araujo-Jorge TC, Miranda CF, de Souza W, Barbosa HS. Interaction of Trypanosoma cruzi with heart muscle cells: ultra-structural and cytochemical analysis of endocytic vacuole formation and effect upon myogenesis in vitro. Eur J Cell Biol 1986; 41:198-206.
7. Aprigliano O, Masuda MO, Meirelles MN, Pereira MC, Barbosa HS, Barbosa JC. Heart muscle cells acutely infected with Trypanosoma cruzi: characterization of electrophysiology and neurotransmitter responses. J Mol Cell Cardiol 1993; 25:1265-74.
8. Barbosa HS, Meirelles MN. Evidence of participation of cytoskeleton of heart muscle cells during the invasion of Trypanosoma cruzi. Cell Struct Funct 1995; 20:275-84.
9. i responses in primary cultures of mouse cardiomyocytes induced by Trypanosoma cruzi trypomastigotes. Mem Inst Oswaldo Cruz 2003; 98:487-93.
10. Taniwaki NN, Machado FS, Massensini AR, Mortara RA. Trypanosoma cruzi disrupts myofibrillar organization and intracellular calcium levels in mouse neonatal cardiomyocytes. Cell Tissue Res 2006; 324:489-96.
11. Moreno SN, Silva J, Vercesi AE, Docampo R. Cytosolicfree calcium elevation in Trypanosoma cruzi is required for cell invasion. J Exp Med 1994; 180:1535-40.
12. 2+ mobilization and microfilament rearrangement in host cells. J Cell Biol 1995; 129:1263-73.
13. 2+ mobilization in rat cardiac myocytes. Exp Parasitol 1994; 78:149-60.
14. de Carvalho AC, Tanowitz HB, Wittner M, Dermietzel R, Roy C, Hertzberg EL et al. Gap junction distribution is altered between cardiac myocytes infected with Trypanosoma cruzi. Circ Res 1992; 70:733-42.
15. Adesse D, Garzoni LR, Huang H, Tanowitz HB, de Nazareth Meirelles M, Spray DC. Trypanosoma cruzi induces changes in cardiac connexin43 expression. Microbes Infect 2008; 10:21-8.
16. Furstenau M, Lohn M, Ried C, Luft FC, Haller H, Gollasch M. Calcium sparks in human coronary artery smooth muscle cells resolved by confocal imaging. J Hypertens 2000; 18:1215-22.
17. Nagajyothi F, Desruisseaux M, Bouzahzah B, Weiss LM, Andrade Ddos S, Factor SM, et al. Cyclin and caveolin expression in an acute model of murine Chagasic myocarditis. Cell Cycle 2006; 5:107-12.
18. Sargiacomo M, Sudol M, Tang Z, Lisanti MP. Signal transducing molecules and glycosyl-phosphatidylinositol-linked proteins form a caveolin-rich insoluble complex in MDCK cells. J Cell Biol 1993; 122:789-807. (Pubitemid 23241090)
19. Williams TM, Lisanti MP. The Caveolin genes: from cell biology to medicine. Ann Med 2004; 36:584-95.
20. Tourkina E, Richard M, Gööz P, Bonner M, Pannu J, Harley R, et al. Antifibrotic properties of caveolin-1 scaffolding domain in vitro and in vivo. Am J Physiol Lung Cell Mol Physiol 2008; 294:843-61.
21. Song KS, Scherer PE, Tang Z, Okamoto T, Li S, Chafel M, et al. Expression of caveolin-3 in skeletal, cardiac and smooth muscle cells. Caveolin-3 is a component of the sarcolemma and co-fractionates with dystrophin and dystrophin-associated glycoproteins. J Biol Chem 1996; 271:15160-5. (Pubitemid 26197582)
22. Woodman SE, Park DS, Cohen AW, Cheung MW, Chandra M, Shirani J, et al. Caveolin-3 knock-out mice develop a progressive cardiomyopathy and show hyperactivation of the p42/44 MAPK cascade. J Biol Chem 2002; 277:38988-97. (Pubitemid 35154765)
23. Gillespie-Brown J, Fuller SJ, Bogoyevitch MA, Cowley S, Sugden PH. The mitogen-activated protein kinase kinase MEK1 stimulates a pattern of gene expression typical of the hypertrophic phenotype in rat ventricular cardiomyocytes. J Biol Chem 1995; 270:28092-6.
24. Engelman JA, Chu C, Lin A, Jo H, Ikezu T, Okamoto T, et al. Caveolin-mediated regulation of signaling along the p42/44 MAP kinase cascade in vivo. A role for the caveolin-scaffolding domain. FEBS Lett 1998; 428:205-11.
25. Mukherjee S, Huang H, Petkova SB, Albanese C, Pestell RG, Braunstein VL, et al. Trypanosoma cruzi infection activates extracellular signal-regulated kinase in cultured endothelial and smooth muscle cells. Infect Immun 2004; 72:5274-82.
26. Huang H, Petkova SB, Cohen AW, Bouzahzah B, Chan J, Zhou J-N, et al. Activation of Transcription factors (AP-1 and NFeκB) in Murine Chagasic Myocarditis. Activation of transcription factors AP-1 and NFeκB in murine Chagasic myocarditis. Infect Immun 2003; 71:2859-67.
27. Tardieux I, Webster P, Ravesloot J, Boron W, Lunn JA, Heuser JE, et al. Lysosome recruitment and fusion are early events required for trypanosome invasion of mammalian cells. Cell 1992; 71:1117-30. (Pubitemid 23016547)
28. Mott A, Lenormand G, Costales J, Fredberg JJ, Burleigh BA. Modulation of host cell mechanics by Trypanosoma cruzi. J Cell Physiol 2009; 218:315-22.
29. Pereira MC, Costa M, Chagas Filho C, de Meirelles MN. Myofibrillar breakdown and cytoskeletal alterations in heart muscle cells during invasion by Trypanosoma cruzi: immunological and ultrastructural study. J Submicrosc Cytol Pathol 1993; 25:559-69.
30. Langer GA, Frank JS. Lanthanum in heart cell culture. Effect on calcium exchange correlated with its localization. J Cell Biol 1972; 54:441-55.
31. Miller TW, Tormey JM. Calcium displacement by lanthanum in subcellular compartments of rat ventricular myocytes: characterization by electron probe microanalysis. Cardiovasc Res 1993; 27:2106-12.
32. Soeiro MN, Silva-Filho FC, Meirelles MN. The nature of anionic sites and the endocytic pathway in heart muscle cells. J Submicrosc Cytol Pathol 1994; 26:121-30.
33. Li J, Scherl A, Medina F, Frank PG, Kitsis RN, Tanowitz HB, et al. Impaired phagocytosis in caveolin-1 deficient macrophages. Cell Cycle 2005; 4:1599-607. (Pubitemid 41609143)
34. Lohn M, Furstenau M, Sagach V, Elger M, Schulze W, Luft FC, et al. Ignition of calcium sparks in arterial and cardiac muscle through caveolae. Circ Res 2000; 87:1034-9.
35. Cohen AW, Hnasko R, Schubert W, Lisanti MP. Role of caveolae and caveolins in health and disease. Physiol Rev 2004; 84:1341-79. (Pubitemid 39287953)
36. Park DS, Woodman SE, Schubert W, Cohen AW, Frank PG, Chandra M, et al. Caveolin-1/3 double-knockout mice are viable, but lack both muscle and non-muscle caveolae, and develop a severe cardiomyopathic phenotype. Am J Pathol 2002; 160:2207-17.
37. Cohen AW, Park DS, Woodman SE, Williams TM, Chandra M, Shirani J, et al. Caveolin-1 null mice develop cardiac hypertrophy with hyperactivation of p42/44 MAP kinase in cardiac fibroblasts. Am J Physiol Cell Physiol 2003; 284:457-74. (Pubitemid 36120083)
38. Augustus AS, Buchanan J, Gutman E, Rengo G, Pestell RG, Fortina P, et al. Hearts lacking caveolin-1 develop hypertrophy with normal cardiac substrate metabolism. Cell Cycle 2008; 7:2509-18.
39. Garzoni LR, Caldera A, Meirelles Mde N, de Castro SL, Docampo R, Meints GA, et al. Selective in vitro effects of the farnesyl pyrophosphate synthase inhibitor risedronate on Trypanosoma cruzi. Int J Antimicrob Agents 2004; 23273-85. (Pubitemid 38283597)